BioHistory Moment: Iditarod Trail used to transport diphtheria serum to Nome.

In 1925, a life-or-death race to save the children of Nome from a diphtheria epidemic made an international hero of one sled dog, and led to the creation of Alaska's Iditarod sled dog race. A diphtheria epidemic threatened remotely located Nome, and air transportation was unavailable to transport serum from Anchorage nearly a thousand miles away.

The solution: A relay of dog teams transported serum on the Iditarod Trail from Nenana to Nome, and every village enroute provided its best team and driver for the next leg continually moving the serum toward Nome. Gunnar Kaasen, a Norwegian musher, drove the final two legs into Nome behind his lead dog Balto through a blizzard with 80 mph winds to deliver 300,000 units of diphtheria antitoxin to Dr. Curtis Welch, the only doctor in Nome.

The serum arrived in time, prevented the epidemic and saved hundreds of lives. The 20 mushers had covered nearly 700 miles in slightly more than 127 hours in temperatures of minus40° Fahrenheit below zero and strong winds. The serum run received worldwide press coverage and the mushers received special gold medals and other recognition. In 1926, a statue of Balto, the heroic lead dog, was erected in New York's Central Park.

Learn about Seattle's PNDRI Life Sciences Incubator Building

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Washington, regionally or nationwide.

Industry News...

Free News Release Posting & Archiving Service


• OncoGenex reports financial results for fourth quarter and fiscal year 2009  Revenue for the fourth quarter and full year of 2009 was $25.5 million, consisting of partial recognition of the non-refundable up-front payments received from Teva in December 2009.
  OncoGenex Pharmaceuticals, Inc.  March 08, 2010  
  
  
• Lilly to acquire European rights to Pfizer Animal Health assets  Elanco, the animal health division of Eli Lilly and Company, announced that Lilly has signed an agreement to acquire the European rights to a portfolio of certain Pfizer Animal Health products.
  Eli Lilly and Company  March 08, 2010  
  
  
• NxStage announces new FREEDOM data  NxStage Medical announced the latest interim results from its ongoing FREEDOM study, which show the significant improvement of overall sleep quality and marked improvement in Restless Legs Syndrome (RLS) experienced by patients after four months of daily home hemodialysis therapy.
  NxStage Medical, Inc.  March 08, 2010  
  
  
• FDA approves NerPharMa to manufacture Cell Therapeutics' drug Pixantrone  Cell Therapeutics announced that the FDA has completed its inspection of the facility in Nerviano, Italy, which manufactures the CTI's drug pixantrone and has found the site in compliance and acceptable for continued manufacturing of the drug product.
  Cell Therapeutics, Inc.  March 08, 2010  
  
  
• Agilent Technologies' executive vice president and CFO Adrian Dillon to leave company  Agilent Technologies announced that Adrian T. Dillon will resign his position as executive vice president, finance and administration, and CFO, effective April 1. Dillon will become chief financial and administration officer at Skype, based in Luxembourg.
  Agilent Technologies Inc.  March 05, 2010  
  
  

More... | Submit News Release | Advertising...

New Job Postings...

The Recruiter’s Studio: People, Careers, Conversations

• Senior Research Associate, CMC (Chemistry, Manufacturing and Controls) Oncothyreon Inc. (WA)
• Preclinical Research Coordinator Oncothyreon Inc. (WA)
• Supply Chain Manufacturing Engineer Light Sciences Oncology, Inc. (WA)
• Clinical Research Nurse Supervisor Puget Sound Blood Center (WA)
• CMC Associate Project Manager Seattle Genetics, Inc. (WA)

More... | Job Advertising...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

• 890 Embarcadero Road Property -- West Sacramento, CA
• CompleGen Lab/Office Space -- Seattle, WA
• Life Sciences Incubator -- Seattle, WA
• University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
• University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

• 03/09/2010: Tren Event: How Green is our Valley: Strategies for Creating a Sustainable New World
• 03/09/2010: Medical Device Breakfast Series: Strategies to Expedite Revenue
• 03/09/2010: Differentiating Cell Types as a Precondition for Diagnosing and Treating Cancer
• 03/09/2010: 14th International Congress on Infectious Diseases
• 03/09/2010: Online Webinar: EDC and EHR in Clinical Trials

More... | Submit Event | Event Advertising...